| 000 | 01479 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250514003253.0 | ||
| 264 | 0 | _c20011204 | |
| 008 | 200112s 0 0 eng d | ||
| 022 | _a0149-2918 | ||
| 024 | 7 |
_a10.1016/s0149-2918(01)80082-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSauriol, L | |
| 245 | 0 | 0 |
_aMeta-analysis comparing newer antipsychotic drugs for the treatment of schizophrenia: evaluating the indirect approach. _h[electronic resource] |
| 260 |
_bClinical therapeutics _cJun 2001 |
||
| 300 |
_a942-56 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
| 650 | 0 | 4 | _aBenzodiazepines |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aHaloperidol _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aOlanzapine |
| 650 | 0 | 4 |
_aPirenzepine _xadverse effects |
| 650 | 0 | 4 | _aPsychiatric Status Rating Scales |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aRisperidone _xadverse effects |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLaporta, M | |
| 700 | 1 | _aEdwardes, M D | |
| 700 | 1 | _aDeslandes, M | |
| 700 | 1 | _aRicard, N | |
| 700 | 1 | _aSuissa, S | |
| 773 | 0 |
_tClinical therapeutics _gvol. 23 _gno. 6 _gp. 942-56 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0149-2918(01)80082-5 _zAvailable from publisher's website |
| 999 |
_c11369215 _d11369215 |
||